MedTrace Logo

Evaluating the Effects of Community Delivery of Malaria Intermittent Preventive Treatment on Pregnant Women and Babies

NCT03600844 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10602

Last updated 2022-03-31

No results posted yet for this study

Summary

This study evaluates the effectiveness of community delivery of sulfadoxine-pyrimetamine (SP) for intermittent preventive treatment of malaria in pregnancy (IPTp) in increasing the coverage of IPTp among pregnant women in selected districts in Democratic Republic of Congo (DRC), Madagascar, Mozambique and Nigeria, compared to comparison districts where SP for IPTp is distributed as usual in facilities through routine antenatal care (ANC).

Conditions

  • Malaria in Pregnancy

Interventions

BEHAVIORAL

Community distribution of SP for IPTp

SP is distributed to eligible pregnant women by trained Community Health Workers (CHWs) at community level. Demand creation activities are implemented within the community as well.

Sponsors & Collaborators

  • Barcelona Institute for Global Health

    collaborator OTHER

  • Jhpiego

    lead OTHER

Principal Investigators

  • Clara Menendez, MD, PhD · Barcelona Institute for Global Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-02
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Democratic Republic of the Congo
  • Madagascar
  • Mozambique
  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03600844 on ClinicalTrials.gov